Senestech (NASDAQ:SNES) Major Shareholder Purchases $24,371.25 in Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 36,375 shares of the firm’s stock in a transaction on Tuesday, October 20th. The stock was acquired at an average price of $0.67 per share, for a total transaction of $24,371.25. Following the completion of the transaction, the insider directly owned 2,099,473 shares of the company’s stock, valued at approximately $1,406,646.91. This trade represents a 1.76% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Thursday, October 22nd, Glenbrook Capital Management purchased 7,500 shares of Senestech stock. The stock was purchased at an average price of $0.80 per share, with a total value of $6,000.00.
• On Wednesday, October 21st, Glenbrook Capital Management acquired 60,000 shares of Senestech stock. The stock was acquired at an average price of $0.74 per share, for a total transaction of $44,400.00.
• On Monday, October 19th, Glenbrook Capital Management purchased 376,552 shares of Senestech stock. The stock was acquired at an average price of $0.70 per share, with a total value of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management bought 181,252 shares of Senestech stock. The stock was bought at an average cost of $0.63 per share, for a total transaction of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management acquired 426,000 shares of Senestech stock. The shares were bought at an average cost of $0.77 per share, with a total value of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management purchased 6,490 shares of Senestech stock. The shares were purchased at an average price of $1.30 per share, with a total value of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management bought 15,000 shares of Senestech stock. The stock was acquired at an average cost of $1.30 per share, with a total value of $19,500.00.

Senestech Stock Performance

Senestech stock opened at $0.84 on Friday. The company’s 50-day moving average price is $0.88 and its 200-day moving average price is $1.31. The company has a quick ratio of 5.81, a current ratio of 6.78 and a debt-to-equity ratio of 0.02. Senestech, Inc. has a twelve month low of $0.55 and a twelve month high of $3.85. The company has a market cap of $4.55 million, a PE ratio of -0.61 and a beta of 0.25.

Senestech (NASDAQ:SNES) last issued its quarterly earnings data on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.02. The business had revenue of $0.77 million for the quarter, compared to the consensus estimate of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. On average, equities research analysts forecast that Senestech, Inc. will post -1.28 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Senestech stock. Diversify Wealth Management LLC bought a new stake in Senestech, Inc. (NASDAQ:SNES) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned about 0.36% of Senestech at the end of the most recent reporting period. 5.19% of the stock is currently owned by institutional investors and hedge funds.

About Senestech

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.